BSE: 524723
Arvaya Healthcare Limited
Rebranded from Bijoy Hans Limited to Arvaya Healthcare Limited effective 13 July 2026 on BSE, and is pivoting into healthcare through the proposed 100% acquisition of Sushodha Institute of Gastroenterology (SIGPL), a super-specialty gastroenterology hospital in Shivamogga. The deal is valued at about Rs 15.49 crore via a share swap of 38.71 lakh equity shares at Rs 40 each, pending shareholder approval via postal ballot. The acquirer's standalone FY26 revenue is Rs 9.11 crore, with total assets of Rs 140.62 crore and an EBITDA margin of 23.3%. Costs are dominated by other operating expenses at 57.3% of revenue, followed by employee costs at 20.8%, depreciation at 6.8% and materials at 6.8%. The board has also approved a Rights Issue of up to Rs 210 crore and is shifting the registered office from Assam to Maharashtra, while appointing a new Executive Director previously at SeCURE Hospitals, Cloudnine, Vaatsalya, and Vikram Hospitals. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Gastroenterology hospital services. Small, transition-stage healthcare services company; single-asset acquisition pending
Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY26 |
|---|---|
| Revenue | 9 |
| EBITDA (ex other income) | 1 |
| margin % | 7.9 |
| Owners' profit | 1 |
| EPS, as reported (₹) | 0.69 |
| ROE % · ROCE % | 1.4 · 1.4 |
| Debt / equity (x) | 0.17 |
| Cash from operations | (3) |
| Capex | (5) |
Exhibit 2: Quarterly performance, last 2 quarters
| ₹ crore | Q4 FY26 | Q1 FY27 |
|---|---|---|
| Revenue | 9 | 30 |
| Profit before tax | 2 | 1 |
| Net profit | 1 | 1 |
| EPS (₹) | 1.25 | 0.08 |
Exhibit 3: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 21 Sept 2026 · Arvaya Healthcare 41st AGM: Subsidiary, Acquisition and Rights Issue Announced | board shareholder meetings | medium | — | — |
| 19 Sept 2026 · Arvaya Healthcare sets up insurance broking subsidiary | strategic transactions | medium | — | — |
| 29 Aug 2026 · Newspaper publication of 41st AGM notice by Arvaya Healthcare | compliance | minimal | — | — |
| 28 Aug 2026 · AGM web link notice for 21 Sept 2026 meeting | board shareholder meetings | low | — | — |
| 28 Aug 2026 · 41st Annual Report for FY 2025-26 and AGM Notice filed | board shareholder meetings | medium | — | — |
| 28 Aug 2026 · Arvaya Healthcare 41st AGM Sep 21, 2026; RPTs and IP acquisition on agenda | board shareholder meetings | low | — | — |
| 27 Aug 2026 · Arvaya Healthcare: 41st AGM notice published in newspapers | compliance | minimal | — | — |
| 26 Aug 2026 · Board Approves IP Portfolio Buy from Related Party for Up to 10 Crore | regulatory legal | medium | — | — |
| 21 Aug 2026 · Board to consider acquisition from related party on Aug 26 | strategic transactions | high | — | — |
| 21 Aug 2026 · Registered office shift from Assam to Maharashtra | compliance | minimal | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.